Title Credit Series date Member price Non-member pricesort descending
2025 Psychopharmacology Update
2.75 NAPNAP Contact Hour of which 2.75 pharmacology content, 2.75 are Psychopharmacology content and 0.25 are Controlled Substance content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses.  Children and adolescents with behavioral health conditions are commonly seen in all pediatric environments. We will focus on the emerging use of long-acting formulations for management of chronic psychiatric conditions and other new pharmacologic approaches to behavioral health management. This presentation is solely focused on pharmacology and aims to help demystify these medications for the pediatric provider. NAPNAP’s Developmental Behavioral and Mental Health SIG is pleased to support this session.
    • 2.75 Contact hours
 08/29/2025 to 08/31/2027 $0.00 $0.00
New Pediatric Antibiotic Prescribing Guidelines
1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. 
    • 1.00 Contact hours
 08/29/2025 to 08/31/2027 $0.00 $0.00
Keeping Current in Atopic Diseases
1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session.
    • 1.25 Contact hours
 08/29/2025 to 08/31/2027 $0.00 $0.00
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting
Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with NAPNAP Partners for Vulnerable Youth. This continuing education activity is offered free for NAPNAP members and nonmembers.
    • 1.50 Contact hours
 10/06/2020 to 08/29/2027 $0.00 $0.00
Meningococcal Prevention: Real Stories, Real Questions, and Real Impact

1.0 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
    • 1.00 Contact hours
 01/18/2026 to 01/31/2027 $0.00 $0.00
Influenza 2025-2026: Is Your Pediatric Practice Ready?
1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. As we enter influenza season, pediatric-focused APRNs can increase their knowledge and prepare to counsel families and restore confidence in influenza vaccines. This continuing education presentation will teach providers to balance communication of scientific data and vaccine efficacy with acknowledgment of parental concerns and fears, and help families feel empowered to make the best decisions when it comes to flu prevention.
    • 1.00 Contact hours
 11/14/2025 to 11/30/2026 $0.00 $0.00
Leucovorin in Autism: An Evidence-Based and Clinically Informed Approach
1.25 NAPNAP Contact Hours of which 1.25 contains pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. This presentation synthesizes the evidence on folinic acid in autism, with an emphasis on advances since 2018 within the context of foundational work. We will examine the pathophysiology of cerebral folate deficiency (CFD), clarify genetic contributors (e.g., FOLR1 and folate-pathway variants), and review clinical testing with folate receptor-α autoantibodies and related labs. Practical treatment guidance will cover formulation selection, dosing and titration, monitoring, adverse effects, and pharmacy/compounding and cost considerations. Taught by a clinician with extensive real-world experience, the presentation highlights where the evidence is strongest and how to implement it. Learners will finish with a concise, evidence-based framework for evaluating and managing CFD in autism within standard practice.
    • 1.25 Contact hours
 11/12/2025 to 11/30/2027 $0.00 $0.00
JPHC CE: Patellofemoral Pain Syndrome in Adolescents: Continuing Education for the Primary Care Provider
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Patellofemoral Pain Syndrome (PFPS) is a multifactorial complaint of anterior knee pain. Patellofemoral pain typically spreads diffusely across the knee, is notable during weight bearing, and is exacerbated by knee flexion. Patellofemoral pain is often insidious in onset, typically with no identifiable mechanism of injury. Factors believed to contribute to PFPS include overuse, muscular imbalance, joint malalignment, and, rarely, trauma to the joint (Bump & Lewis, 2023). J Pediatr Health Care (2025) 39, 686-694.
    • 1.00 Contact hours
 07/01/2025 to 08/31/2026 $0.00 $10.00
NP Preceptor: Telehealth Interprofessional Practice
0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $5 for NAPNAP Members. For non- members, this continuing education activity rate is $10. This module will introduce telehealth delivered by Nurse Practitioners in the context of a primary care practice.  This module introduces the basic concepts of Telehealth Interprofessional Practice. The module takes approximately 30 minutes to complete and you may complete it at your own pace.  Pre-Test - Please complete the pre-test. It only takes about 3 minutes. Test results are reported as AGGREGATE DATA ONLY for us to evaluate the effectiveness of each learning module.
    • 0.50 Contact hours
 07/30/2019 to 06/30/2026 $5.00 $10.00
JPHC CE: Approaches to Treating Children With ADHD and Common Comorbidities
1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx), (1.0 is related to psychopharmacology), (0.25 is related to controlled substance). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Attention Deficit Hyperactivity Disorder (ADHD) is the most common mental health disorder among children and adolescents, with a prevalence rate of 9.8% in children 3 to 17 years of age (Bitsko et al., 2022). The American Academy of Pediatrics (AAP) has published guidelines for treatment of ADHD in children and adolescents ages 4 to 17 years that address diagnosis, treatment and monitoring of ADHD (Wolraich et al., 2019). The AAP guidelines do not address treatment of children with co-morbidities but identify the treatment of ADHD in children with comorbidities as an area for future research. To address this gap, a review of ADHD treatment in children with comorbidities including anxiety, depression, substance use disorder (SUD), epilepsy, tic disorders (TD), oppositional defiant disorder (ODD), learning disabilities (LD), autism spectrum disorder (ASD) and sleep disorders was conducted. J Pediatr Health Care. (2025) 39, 318-325.
    • 1.00 Contact hours
 03/01/2025 to 04/30/2026 $0.00 $10.00
JPHC CE: Preventing Suicide Through Lethal Means Restriction in Pediatric Care
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. This article explores the data and practice evidence for lethal means restriction and counseling, focusing on clinical strategies and policy changes to reduce access to lethal means. Emphasis is given to how pediatric providers speak with parents about the importance of restricting access when developing a safety plan. J Pediatr Health Care. (2025) 39, 308-317.
    • 0.75 Contact hours
 03/01/2025 to 04/30/2026 $0.00 $10.00
JPHC CE: Diagnosis and Management of Pediatric Allergic Rhinoconjunctivitis in the US
1.0 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Allergic rhinoconjunctivitis (AR/C) is a common pediatric condition. The physical, emotional, and social burden of AR/C in children highlights the need for accurate diagnosis with optimal treatment. This review provides practical information on the diagnosis and management of pediatric AR/C. Key features of the patient history and physical exam needed to diagnose seasonal and perennial AR/C are covered. Various AR/C treatment options are reviewed such as allergen avoidance, pharmacotherapies, and allergy immunotherapy (both subcutaneous injections and sublingual tablets) as well as their mode of action, side effects, and their role in guideline-recommended therapy. Practical information such as pollen calendars, management algorithms, and treatment product characteristics have also been included in this review. J Pediatr Health Care. (2025) 39, 489-502.
    • 1.00 Contact hours
 05/01/2025 to 06/30/2026 $0.00 $10.00
JPHC CE: Sexting and Sextortion in Adolescents: Essentials for the PNP
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sexting and sextortion are increasingly common concerns among adolescents, presenting significant challenges for pediatric nurse practitioners (PNPs). Sexting, or digital sharing of self-produced nude or otherwise sexual images, is increasingly seen as a normative part of adolescent sexual exploration, but carries substantial risks, particularly when images are shared non-consensually, by minors, or used as a method of bullying or extortion (“sextortion”). PNPs play a critical role in early identification of any nonconsensual texting and by providing education to adolescents so they may explore their sexuality safely, resist peer pressure, and maintain boundaries. J Pediatr Health Care (2026) 40, Issue 1, P162-173.
    • 1.00 Contact hours
 01/01/2026 to 02/28/2027 $0.00 $10.00
JPHC CE: The Resurgence of Syphilis: A Critical Public Health Concern
1.25 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Syphilis, a sexually transmitted infection caused by Treponema pallidum, has become a concerning resurgence in recent years, particularly in the United States. Of significant concern is the steep rise in congenital syphilis cases, which poses grave risks to maternal and neonatal health. This article provides an overview of the epidemiology, risk factors, clinical manifestations, screening methods, and treatment strategies for syphilis, with a specific focus on congenital transmission. Drawing upon current literature and guidelines, the paper underscores the importance of early detection and intervention to prevent adverse outcomes associated with congenital syphilis. Furthermore, the article highlights the challenges in syphilis diagnosis, including the interpretation of serological tests and the management of neurosyphilis. Recommendations for practice, including screening protocols and treatment regimens, are discussed in detail. The conclusion emphasizes the urgent need for collaborative efforts among healthcare providers, public health agencies, and community stakeholders to address the syphilis epidemic effectively. By adhering to evidence-based guidelines and leveraging available resources, clinicians can play a pivotal role in reducing the burden of syphilis and safeguarding the health of vulnerable populations, particularly pregnant women and infants. J Pediatr Health Care. (2025) 39, 479-488.
    • 1.25 Contact hours
 05/01/2025 to 06/30/2026 $0.00 $10.00
JPHC CE: Trauma Exposure in Migrant Children: Implications for Mental and Physical Health
1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Global migration is a public health crisis of epidemic proportions. Migrants are at risk for a variety of physical and mental health concerns, while having limited access to healthcare. Migrant children are especially vulnerable to experiencing significant trauma, both physical and emotional. Children comprise less than one third of the global population, yet nearly half of migrants are children less than 18 years of age. The United States is home to a significant number of migrant children. Migrant children have a unique set of educational, health, and emotional needs. Given the sheer number of migrant children living in the U.S., pediatric nurse practitioners (PNP) must understand their unique needs and provide evidence-based interventions to help meet these needs. This continuing education article will discuss migrant children in terms of understanding migration, trauma exposure and resultant impact on psychological and physical health, and implications for practice. J Pediatr Health Care (2025) 40, 1-12.
    • 1.50 Contact hours
 09/01/2025 to 10/31/2026 $0.00 $10.00

Pages